Insider Transactions Reported by 18 Insiders of 2seventy bio, Inc.

Location
Cambridge, MA

Insiders trading volume in the past year

2seventy bio, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Kynam Capital Management, LP 10%+ Owner $61,293,964 10 Aug 2023
Casdin Capital, LLC Director $12,893,491 13 May 2025
Philip D. Gregory Chief Scientific Officer $1,789,046 05 Jan 2024
William Baird President and CEO, Director $691,680 -$25,180 -3.5% 13 May 2025
Nicola Heffron Chief Operating Officer $668,804 07 Feb 2023
Victoria Eatwell Chief Financial Officer $282,960 -$12,817 -4.3% 13 May 2025
Jessica Snow Chief Operating Officer $278,048 -$11,364 -3.9% 13 May 2025
DANIEL LYNCH Director $145,442 13 Jun 2023
Ramy Ibrahim Director $137,923 13 Jun 2023
Marcela Maus V. Director $94,713 13 May 2025
Sarah JS Glickman Director $94,713 13 May 2025
Lin Wei Director $94,713 13 May 2025
Denice Torres Director $94,713 13 May 2025
Charles W. Newton Director $47,357 13 May 2025
William R. Sellers Director $24,670 11 Nov 2021
Nick Leschly Director $0 13 May 2025
Kynam Global Healthcare Master Fund, LP 10%+ Owner $0 -$80,053,572 -100% 11 Mar 2025
bluebird bio, Inc. 10%+ Owner 03 Nov 2021

Recent Insider Transactions by Companies or Individuals for 2seventy bio, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.